Robert Prentice Nickell

US Patent:

20090233970, Sep 17, 2009

Filed:

Mar 11, 2008

Appl. No.:

12/046327

Inventors:

ROBERT P. NICKELL - Torrance CA, US

International Classification:

A61K 31/435
A61K 31/196
A61K 31/407
A61K 31/192
A61K 31/4164
A61K 31/341
A61P 29/00
A61P 25/00
A61K 31/426
A61K 31/421
A61K 31/40
A61K 31/405

US Classification:

514338, 514567, 514411, 514570, 514374, 514569, 514423, 514420, 514400, 514370, 514365, 514471

Abstract:

The present invention is directed to co-administration of a non-steroidal anti-inflammatory agent (NSAID) and acid blocking agent for the treatment of pain and inflammation with reduced gastrointestinal irritation. A pharmaceutical composition suitable for the co-administration contains a therapeutically effective amount of at least one non-steroidal anti-inflammatory agent, and a therapeutically effective amount of at least one acid blocking agent. A ratio of the non-steroidal anti-inflammatory agent to acid blocking agent in the composition is within a range that provides greater pain relief and reduction of inflammation with less gastrointestinal irritation than that obtainable by the administration of the non-steroidal anti-inflammatory agent or acid blocking agent alone. Examples of pharmaceutical compositions for co-administration of the agents are those containing ibuprofen and ranitidine (“ibudine”), as well as naproxen and ranitidine (“naprodine”).

US Patent:

20090264454, Oct 22, 2009

Filed:

Apr 16, 2008

Appl. No.:

12/104374

Inventors:

Robert P. Nickell - Torrance CA, US

International Classification:

A61K 31/485
A61P 29/00
A61P 25/00

US Classification:

514282

Abstract:

The present invention is directed to co-administration of hydrocodone and a second analgesic agent for the treatment of pain. A pharmaceutical composition suitable for the co-administration contains a therapeutically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of at least one second analgesic agent. A ratio of the hydrocodone or pharmaceutically acceptable salt thereof to the at least one second analgesic agent in the composition is within a range that provides greater pain relief than that obtainable by the administration of the hydrocodone or second analgesic agent alone. Examples of pharmaceutical compositions for co-administration of the agents are those containing hydrocodone and indomethacin (“Indocodone”), hydrocodone and naproxen (“Naprocodone”), hydrocodone and diclofenac (“Diclodone”) and hydrocodone and tramadol (“Tramacodone”).

US Patent:

20090264530, Oct 22, 2009

Filed:

Apr 16, 2008

Appl. No.:

12/104372

Inventors:

Robert P. Nickell - Torrance CA, US

International Classification:

A61K 31/192
A61K 31/167
A61P 25/00
A61P 29/00

US Classification:

514568, 514629

Abstract:

The present invention is directed to co-administration of a non-steroidal anti-inflammatory agent (NSAID) and acetaminophen for the treatment of pain and inflammation with reduced gastrointestinal irritation. A pharmaceutical composition suitable for the co-administration contains a therapeutically effective amount of at least one non-steroidal anti-inflammatory agent, and a therapeutically effective amount of acetaminophen or a pharmaceutically acceptable salt thereof. A ratio of the non-steroidal anti-inflammatory agent to acetaminophen in the composition is within a range that provides greater pain relief and reduction of inflammation with less gastrointestinal irritation than that obtainable by the administration of the non-steroidal anti-inflammatory agent or acetaminophen alone. Examples of pharmaceutical compositions for co-administration of the agents are those containing ibuprofen in combination with the acetaminophen.

US Patent:

20070255595, Nov 1, 2007

Filed:

Jun 21, 2007

Appl. No.:

11/820960

Inventors:

Robert Nickell - Torrance CA, US

International Classification:

G06Q 10/00
A61B 5/00

US Classification:

705002000, 600300000

Abstract:

A method for compounding pharmaceuticals, which includes placing an order for compounded pharmaceuticals, scheduling a date for the compounding, scheduling a location for the compounding, ordering the necessary chemicals required, providing the requested formulations, providing the actual compounding of the pharmaceuticals, and providing necessary equipment and staff for the compounding. A computer software program that facilitates the interaction between parties in a pharmaceutical compounding relationship. A portable pharmaceutical compounding lab that may be used in the method for compounding pharmaceuticals.

US Patent:

20160167871, Jun 16, 2016

Filed:

Feb 24, 2016

Appl. No.:

15/052524

Inventors:

- Torrance CA, US
Robert P. Nickell - Torrance CA, US

Assignee:

ASCLEMED USA, INC. dba EnovaChem Manufacturing - Torrance CA

International Classification:

B65D 85/00
A61F 13/00
A41D 13/11
A41D 19/00
B65D 5/64
B65D 1/09

Abstract:

Provided is a kit comprising a compound having vitamin B-12 activity in a form that is suitable for injection. The kit can be in the form of a box with a lid with a number of components placed in the box. The compound having vitamin B-12 activity can be cyanocobalamin, typically in form of a solution in a vial. The kit can contain an alcohol pad. The kit can contain a pair of gloves. The kit can contain a csr wrap. The concentration of the cyanocobalamin can be 1000 mcg/ml. In one embodiment, the kit is a box with a lid and following components placed inside of the box: a) a container having 1 milliliter (mL) of a solution of cyanocobalamin with a concentration of 1000 mcg/ml; b) isopropyl pad; c) a pair of gloves; and d) a csr wrap.

US Patent:

20160136120, May 19, 2016

Filed:

Jan 21, 2016

Appl. No.:

15/003725

Inventors:

- Torrance CA, US
Robert P. Nickell - Torrance CA, US

International Classification:

A61K 31/197
A61J 1/16

Abstract:

Provided are kits containing a base composition and an active pharmaceutical ingredient for transdermal delivery of active pharmaceutical ingredients. Examples of active pharmaceutical ingredients include amitriptyline, baclofen, cyclobenzaprine HCl, ibuprofen, lidocaine HCl, naproxen, and tramadol, ketoprofen, diclofenac, phenylbutazone, mefenamic acid, flubiprofen, piroxicam, guaifenasin, prilocaine, bupivicaine, tetracaine, nifedipine, verapamil, orphenadrine, imipramine, ketamine, gabapentin, carbamazepine, menthol, capsaicin, clonidine, dexamethasone, dextromethorphan, testosterone, progesterone, and estrogens.

US Patent:

20160120712, May 5, 2016

Filed:

Oct 28, 2015

Appl. No.:

14/925848

Inventors:

- Torrance CA, US
Robert P. Nickell - Torrance CA, US

International Classification:

A61F 17/00
A61K 9/00
A61K 31/568

Abstract:

Provided a kit with all the necessary components for a medical practitioner in the office practice setting to inject testosterone to a patient. Specifically, the kit can include a holder and following components placed inside a holder: a) a container of testosterone ester in a formulation that is suitable for injection to an animal; b) a pad for disinfecting or cleaning an injection site; and c) a pair of gloves.

US Patent:

20160120828, May 5, 2016

Filed:

Oct 28, 2015

Appl. No.:

14/925834

Inventors:

- Torrance CA, US
Robert P. Nickell - Torrance CA, US

International Classification:

A61K 31/194
A61K 31/166
A61K 31/07
A61K 31/59
B65D 85/00
A61K 31/4402

Abstract:

Provides is a kit comprising: a) a container; and b) following components placed inside of the container: i) magnesium citrate oral Solution; ii) a laxative in form of an oral pharmaceutical dosage form; iii) a topical formulation for application to the skin to relieve irritation; iii) a container of polyethylene glycol powder; iv) an oral pharmaceutical dosage form for treating nausea; and v) an electrolyte drink mix; wherein the kit is used by a patient to clean the patient's colon prior to a colonoscopy.